[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"$fo3FZpwR4Uq5IPxBwJW51xUfAqWMu3z0db8n43E2wLWs":3},{"_id":4,"client":5,"credits":6,"hero":41,"name":46,"nextWork":47,"orderRank":56,"pageBuilder":57,"services":123,"subhero":124},"8209ff26-6255-484a-9342-eeff6f74bc98","KLISBio",{"credits":7,"team":16,"webStack":10},[8],{"collaborator":9},{"link":10,"name":11,"role":12},null,"Mattia Balsamini, Foto",{"_type":13,"en":14,"it":15},"localeString","Photos","Foto",[17,20,23,26,29,32,35,38],{"collaborator":18},{"link":10,"name":19},"Andrea Bergamini, Partner",{"collaborator":21},{"link":10,"name":22},"Francis Needham, Partner",{"collaborator":24},{"link":10,"name":25},"Irene Salvadeo, Designer",{"collaborator":27},{"link":10,"name":28},"Lucia Pellegrini, Designer",{"collaborator":30},{"link":10,"name":31},"Margherita Schiavon, Developer",{"collaborator":33},{"link":10,"name":34},"Luca Argentieri, Developer",{"collaborator":36},{"link":10,"name":37},"Marcos Valenzuela, Developer",{"collaborator":39},{"link":10,"name":40},"Alessandro Beghelli, Project Manager",{"image":42,"mobileImage":10,"video":10,"videoMobile":10},{"asset":43},{"_id":44,"altText":10,"url":45},"image-c9256b37478e9a6d589fb115cbd951bf9d024d15-3024x1760-jpg","https:\u002F\u002Fcdn.sanity.io\u002Fimages\u002Fesfr8fze\u002Fproduction\u002Fc9256b37478e9a6d589fb115cbd951bf9d024d15-3024x1760.jpg","Identity",{"client":48,"hero":49,"name":54,"slug":55},"Limonta",{"image":50,"mobileImage":10},{"asset":51},{"_id":52,"altText":10,"url":53},"image-7fe23b9d1179b9eaa5982712001457e17c57f095-2880x1760-jpg","https:\u002F\u002Fcdn.sanity.io\u002Fimages\u002Fesfr8fze\u002Fproduction\u002F7fe23b9d1179b9eaa5982712001457e17c57f095-2880x1760.jpg","Lineapelle 2024","\u002Fworks\u002Flimonta-lineapelle-2024","0|100013:zzv",[58,64,74,92,99,105,118],{"_type":59,"image":60,"imageMobile":10},"SingleImage",{"asset":61},{"_id":62,"altText":10,"url":63},"image-bf21a4f7b91a88a24512173b095064a9ddaad38e-2984x1772-jpg","https:\u002F\u002Fcdn.sanity.io\u002Fimages\u002Fesfr8fze\u002Fproduction\u002Fbf21a4f7b91a88a24512173b095064a9ddaad38e-2984x1772.jpg",{"_type":65,"leftBottomColor":10,"leftBottomImage":10,"leftBottomType":66,"leftBottomVideo":67,"leftTopImage":10,"leftTopType":10,"leftTopVideo":10,"rightBottomColor":10,"rightBottomImage":70,"rightBottomType":73,"rightBottomVideo":10,"rightTopImage":10,"rightTopType":10,"rightTopVideo":10},"DoubleMedia","video",{"asset":68},{"url":69},"https:\u002F\u002Fcdn.sanity.io\u002Ffiles\u002Fesfr8fze\u002Fproduction\u002F134f84ec40367b8fd7dd865def590669b3cae5a4.mp4",{"asset":71},{"_id":72,"altText":10},"image-604414728915c9678f6229361e52cb6b8ae900c9-2000x2499-jpg","image",{"_type":75,"slides":76},"Carousel",[77,80,83,86,89],{"asset":78},{"_id":79,"altText":10},"image-a3f86161b24d4e7ce0d2a5201c0ab8bbdde39a45-962x1402-jpg",{"asset":81},{"_id":82,"altText":10},"image-9cd375ba9cb8c6f23bb862f4ca0a60d65a5e0613-962x1402-jpg",{"asset":84},{"_id":85,"altText":10},"image-5a77c341f6d7c7950f3b3b48fda6d6683c673697-962x1402-jpg",{"asset":87},{"_id":88,"altText":10},"image-2c6ad01db835f497a41cd8e3fa39945e7b5d9c32-964x1402-jpg",{"asset":90},{"_id":91,"altText":10},"image-4477d8241295e7e53cf508b0a3d40ed4cad68afe-962x1402-jpg",{"_type":65,"leftBottomColor":10,"leftBottomImage":93,"leftBottomType":73,"leftBottomVideo":10,"leftTopImage":10,"leftTopType":10,"leftTopVideo":10,"rightBottomColor":10,"rightBottomImage":96,"rightBottomType":73,"rightBottomVideo":10,"rightTopImage":10,"rightTopType":10,"rightTopVideo":10},{"asset":94},{"_id":95,"altText":10},"image-0951acc072a82fc9068fe244d62a8ea05268f3fa-1482x1760-jpg",{"asset":97},{"_id":98,"altText":10},"image-8e68b9d5fc494d4386973351e902a540306af177-1482x1760-jpg",{"_type":100,"backgroundImage":10,"backgroundVideo":10,"color":101,"video":102},"ContainedVideo","#000000",{"asset":103},{"url":104},"https:\u002F\u002Fcdn.sanity.io\u002Ffiles\u002Fesfr8fze\u002Fproduction\u002Fcec3be667511a4ed948665f80365f5e5ddaffd73.mp4",{"_type":65,"leftBottomColor":10,"leftBottomImage":106,"leftBottomType":73,"leftBottomVideo":10,"leftTopImage":10,"leftTopType":66,"leftTopVideo":109,"rightBottomColor":10,"rightBottomImage":112,"rightBottomType":73,"rightBottomVideo":10,"rightTopImage":10,"rightTopType":66,"rightTopVideo":115},{"asset":107},{"_id":108,"altText":10},"image-9e48f0849b41781b749cc8f054f229e9ca0c7530-705x823-jpg",{"asset":110},{"url":111},"https:\u002F\u002Fcdn.sanity.io\u002Ffiles\u002Fesfr8fze\u002Fproduction\u002F289e02f763bcdd30d49ab124dab9ac72f4a93b9b.mp4",{"asset":113},{"_id":114,"altText":10},"image-6045f2a42c24e124e2351c055ffa37053f6dc85b-1058x1234-jpg",{"asset":116},{"url":117},"https:\u002F\u002Fcdn.sanity.io\u002Ffiles\u002Fesfr8fze\u002Fproduction\u002F232c843205c71acbbd367d5de8b06c7e5dfe5db0.mp4",{"_type":100,"backgroundImage":10,"backgroundVideo":10,"color":119,"video":120},"#e6e7e9",{"asset":121},{"url":122},"https:\u002F\u002Fcdn.sanity.io\u002Ffiles\u002Fesfr8fze\u002Fproduction\u002F5529ff84138dea5920aedbbd79280e7f82d648e6.mp4",[46],{"altText":10,"overview":125,"title":126,"url":127},"KLISBio sviluppa soluzioni mediche rigenerative basate sulla fibroina di seta, integrando scienza dei materiali, bioingegneria e ricerca chirurgica. Il progetto è iniziato con un workshop analitico finalizzato a chiarire valori, promessa e percezione condivisa dell’azienda, costruendo la base strategica dell’identità.\n\nIl nuovo linguaggio visivo è stato sviluppato attraverso logo, tipografia, naming dei prodotti e art direction di fotografia e video. La precisione scientifica si combina con un’espressione più distintiva e accessibile, capace di comunicare contenuti tecnologici complessi senza ricorrere ai codici più generici del settore biomedicale.\n\nPensato come principale espressione digitale della nuova identità, il sito organizza contenuti corporate, tecnologici e di prodotto in una narrazione chiara. Tipografia, ritmo dell’interfaccia e racconto per immagini supportano diversi livelli di approfondimento tecnico e costruiscono una piattaforma coerente con la crescita dell’azienda.","Un’identità visiva e una piattaforma digitale che traducono la ricerca biomedica di KLISBio sulla fibroina di seta in un sistema chiaro, credibile e contemporaneo.","https:\u002F\u002Fwww.klis.bio\u002F"]